MedPath
NMPA Approval

Hymecromone Capsules

国药准字H43020800

September 20, 2024

Drug Information

羟甲香豆素胶囊

胶囊剂

0.4g

化学药品

September 20, 2024

Company Information

Applicant Company

长沙市浏阳经济技术开发区康平路167号

Manufacturing Company

长沙市浏阳生物医药工业园北园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

羟甲香豆素胶囊 - NMPA 批准文号 | MedPath